Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Management of ocular sarcoidosis.

Baughman RP, Lower EE, Ingledue R, Kaufman AH.

Sarcoidosis Vasc Diffuse Lung Dis. 2012 Mar;29(1):26-33.

PMID:
23311120
2.

Leflunomide for chronic sarcoidosis.

Baughman RP, Lower EE.

Sarcoidosis Vasc Diffuse Lung Dis. 2004 Mar;21(1):43-8.

PMID:
15127974
3.

Infliximab in chronic ocular inflammation.

Baughman RP, Bradley DA, Lower EE.

Int J Clin Pharmacol Ther. 2005 Jan;43(1):7-11.

PMID:
15704608
4.
5.

Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study.

Weisman MH, Moreland LW, Furst DE, Weinblatt ME, Keystone EC, Paulus HE, Teoh LS, Velagapudi RB, Noertersheuser PA, Granneman GR, Fischkoff SA, Chartash EK.

Clin Ther. 2003 Jun;25(6):1700-21.

PMID:
12860493
6.

Concomitant therapy with methotrexate and anti-TNF-α in pediatric patients with refractory crohn's colitis: a case series.

Absah I, Faubion WA Jr.

Inflamm Bowel Dis. 2012 Aug;18(8):1488-92. doi: 10.1002/ibd.21885. Epub 2011 Aug 31.

PMID:
21882301
7.

Long term follow-up of infliximab efficacy in pulmonary and extra-pulmonary sarcoidosis refractory to conventional therapy.

Russell E, Luk F, Manocha S, Ho T, O'Connor C, Hussain H.

Semin Arthritis Rheum. 2013 Aug;43(1):119-24. doi: 10.1016/j.semarthrit.2012.10.008. Epub 2013 Jan 16.

PMID:
23332903
8.

Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.

Strangfeld A, Hierse F, Kekow J, von Hinueber U, Tony HP, Dockhorn R, Listing J, Zink A.

Ann Rheum Dis. 2009 Dec;68(12):1856-62. doi: 10.1136/ard.2008.098467. Epub 2009 Jan 6.

PMID:
19126559
9.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

11.

T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.

Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED.

Am J Gastroenterol. 2013 Jan;108(1):99-105. doi: 10.1038/ajg.2012.334. Epub 2012 Oct 2.

PMID:
23032984
12.

Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term followup.

Schmidt J, Kermani TA, Bacani AK, Crowson CS, Matteson EL, Warrington KJ.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):1079-83. doi: 10.1002/acr.21636.

14.

Adalimumab in the therapy of uveitis in childhood.

Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, Zierhut M.

Br J Ophthalmol. 2007 Mar;91(3):319-24. Epub 2006 Oct 11.

15.

Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.

Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL.

J Rheumatol. 2007 May;34(5):952-7. Epub 2007 Apr 15.

PMID:
17444589
16.

Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.

Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS.

Ann Rheum Dis. 2008 Nov;67(11):1567-9. doi: 10.1136/ard.2008.093260. Epub 2008 Aug 3.

PMID:
18677012
17.

Anti-TNF-α therapy in the management of severe neurosarcoidosis: a report of five cases from a single centre and literature review.

Riancho-Zarrabeitia L, Delgado-Alvarado M, Riancho J, Oterino A, Sedano MJ, Rueda-Gotor J, Pérez-Martín I, González-Vela MC, Berciano J, González-Gay MA, Blanco R.

Clin Exp Rheumatol. 2014 Mar-Apr;32(2):275-84. Epub 2013 Dec 9. Review.

PMID:
24321604
19.

Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.

Erckens RJ, Mostard RL, Wijnen PA, Schouten JS, Drent M.

Graefes Arch Clin Exp Ophthalmol. 2012 May;250(5):713-20. doi: 10.1007/s00417-011-1844-0. Epub 2011 Nov 27.

20.

Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study.

Lahmer T, Knopf A, Lanzl I, Heemann U, Thuermel K.

Rheumatol Int. 2012 Aug;32(8):2367-70. doi: 10.1007/s00296-011-1968-x. Epub 2011 Jun 5.

PMID:
21644042
Items per page

Supplemental Content

Write to the Help Desk